# The Optimal Antibiotic Treatment Duration for Community-acquired Pneumonia in Adults Diagnosed in General Practice in Denmark (CAP-D)

> **NCT06295120** · PHASE4 · RECRUITING · sponsor: **Research Unit for General Practice in Aalborg** · enrollment: 600 (estimated)

## Conditions studied

- Community-acquired Pneumonia

## Interventions

- **DRUG:** Phenoxymethylpenicillin 1.2 MIE 4 times daily

## Key facts

- **NCT ID:** NCT06295120
- **Lead sponsor:** Research Unit for General Practice in Aalborg
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-11-13
- **Primary completion:** 2026-03-31
- **Final completion:** 2026-03-31
- **Target enrollment:** 600 (ESTIMATED)
- **Last updated:** 2025-08-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06295120

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06295120, "The Optimal Antibiotic Treatment Duration for Community-acquired Pneumonia in Adults Diagnosed in General Practice in Denmark (CAP-D)". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06295120. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*